J_SPRAKE_&_PARTNERS_LIMIT - Accounts


Company registration number 06806698 (England and Wales)
J SPRAKE & PARTNERS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
J SPRAKE & PARTNERS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 10
J SPRAKE & PARTNERS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
3
258
341
Tangible assets
4
862,723
775,266
Biological assets
5
406,231
382,470
1,269,212
1,158,077
Current assets
Stocks
163,869
195,009
Debtors
6
140,449
92,153
304,318
287,162
Creditors: amounts falling due within one year
7
(425,122)
(369,847)
Net current liabilities
(120,804)
(82,685)
Total assets less current liabilities
1,148,408
1,075,392
Creditors: amounts falling due after more than one year
8
(953,491)
(957,463)
Provisions for liabilities
(76,823)
(48,827)
Net assets
118,094
69,102
Capital and reserves
Called up share capital
82
82
Profit and loss reserves
118,012
69,020
Total equity
118,094
69,102

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

J SPRAKE & PARTNERS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2023
31 March 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 11 October 2023 and are signed on its behalf by:
Mr John Sprake
Mrs Susan Sprake
Director
Director
Mr Jonathan Sprake
Mr Christopher Sprake
Director
Director
Company Registration No. 06806698
J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 3 -
1
Accounting policies
Company information

J Sprake & Partners Limited is a private company limited by shares incorporated in England and Wales. The registered office is Maltravers House, Petters Way, YEOVIL, Somerset, BA20 1SH. The business address is Bradley Head Farm, Milborne Wick, SHERBORNE, Dorset, DT9 4PW.

1.1
Accounting convention

The financial statements have been prepared under the historical cost convention, The principal accounting policies adopted are set out below.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

BPS entitlements
6 years straight line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings
Land nil/buildings 2% straight line
Plant and machinery
15% reducing balance
Motor vehicles
15% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Biological assets

Biological assets are recognised only when three recognition criteria have been fulfilled:

  •     the entity has control over the asset as a result of past events;

  •     it is probable that future economic benefits associated with the asset will flow to the entity; and

  •     the fair value or cost of the asset can be measured reliably.

The company measures biological assets at cost less accumulated depreciation and accumulated impairment losses.

 

In respect of agricultural produce harvested from a biological asset, this is measured at the point of harvest at lower of cost and estimated selling price less costs to complete and sell.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Dairy
7 years
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 5 -
1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Home grown produce has been valued in accordance with HM Revenue & Customs HS232

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 6 -
1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Government grants
J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 7 -

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
4
7
3
Intangible fixed assets
BPS entitlements
£
Cost
At 1 April 2022 and 31 March 2023
15,860
Amortisation and impairment
At 1 April 2022
15,519
Amortisation charged for the year
83
At 31 March 2023
15,602
Carrying amount
At 31 March 2023
258
At 31 March 2022
341
J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 8 -
4
Tangible fixed assets
Land and buildings
Plant and machinery
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2022
579,785
349,120
238,092
1,166,997
Additions
43,250
68,370
56,738
168,358
Disposals
-
0
(33,100)
(37,051)
(70,151)
At 31 March 2023
623,035
384,390
257,779
1,265,204
Depreciation and impairment
At 1 April 2022
61,505
251,351
78,875
391,731
Depreciation charged in the year
6,098
15,384
25,550
47,032
Eliminated in respect of disposals
-
0
(22,844)
(13,438)
(36,282)
At 31 March 2023
67,603
243,891
90,987
402,481
Carrying amount
At 31 March 2023
555,432
140,499
166,792
862,723
At 31 March 2022
518,280
97,769
159,217
775,266
5
Biological assets
Dairy
£
Cost
At 1 April 2022
491,236
Additions - purchases
185,692
Disposals
(157,039)
At 31 March 2023
519,889
Depreciation and impairment
At 1 April 2022
108,767
Depreciation charged for the year
45,948
Disposals
(41,057)
At 31 March 2023
113,658
Carrying amount
At 31 March 2023
406,231
At 31 March 2022
382,470
J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 9 -
6
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
115,006
79,796
Other debtors
25,443
12,357
140,449
92,153
7
Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans and overdrafts
114,526
141,770
Trade creditors
144,612
84,431
Taxation and social security
43,348
37,108
Other creditors
122,636
106,538
425,122
369,847

The hire purchase liabilities of £65,202 (2022 - £28,497) are secured on the assets to which they relate. The bank loans of £65,118 (2022 - £63,883) are secured by fixed charges over property and assets held by the company. The bank overdraft of £49,408 (2022 - £77,887) is secured on assets owned personally by Mr John Sprake.

8
Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
811,009
877,362
Other creditors
142,482
80,101
953,491
957,463

The hire purchase liabilities of £142,482(2022 - £80,101) are secured on the assets to which they relate. The bank loans of £ 811,009 (2022 - £877,362) are secured by fixed charges over property and assets held by the company.

Creditors which fall due after five years are as follows:
2023
2022
£
£
Payable by instalments
624,551
684,213
J SPRAKE & PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 10 -
9
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2023
2022
£
£
29,106
18,999
10
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Director's loan
2.00
-
117,748
479
(118,227)
-
-
117,748
479
(118,227)
-
11
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

During the year the company made repayments on its loans from the directors totalling £117,589 (2022 - £109,023) and advances were made to the company totalling £96,646 (2022 - £93,455). The loans are unsecured, interest free and repayable on demand.

The following amounts were outstanding at the reporting end date:

2023
2022
Amounts due to related parties
£
£
Directors
51,831
72,774
2023-03-312022-04-01false16 October 2023CCH SoftwareCCH Accounts Production 2023.200No description of principal activityMr John SprakeMrs Susan SprakeMr Jonathan SprakeMr Christopher SprakeMrs S Sprake068066982022-04-012023-03-31068066982023-03-31068066982022-03-3106806698core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-03-3106806698core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-03-3106806698core:LandBuildingscore:OwnedOrFreeholdAssets2023-03-3106806698core:PlantMachinery2023-03-3106806698core:MotorVehicles2023-03-3106806698core:LandBuildingscore:OwnedOrFreeholdAssets2022-03-3106806698core:PlantMachinery2022-03-3106806698core:MotorVehicles2022-03-3106806698core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3106806698core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3106806698core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-3106806698core:Non-currentFinancialInstrumentscore:AfterOneYear2022-03-3106806698core:CurrentFinancialInstruments2023-03-3106806698core:CurrentFinancialInstruments2022-03-3106806698core:Non-currentFinancialInstruments2023-03-3106806698core:Non-currentFinancialInstruments2022-03-3106806698core:ShareCapital2023-03-3106806698core:ShareCapital2022-03-3106806698core:RetainedEarningsAccumulatedLosses2023-03-3106806698core:RetainedEarningsAccumulatedLosses2022-03-3106806698bus:Director12022-04-012023-03-3106806698bus:CompanySecretaryDirector12022-04-012023-03-3106806698bus:Director22022-04-012023-03-3106806698bus:Director32022-04-012023-03-3106806698core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106806698core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106806698core:LandBuildingscore:OwnedOrFreeholdAssets2022-04-012023-03-3106806698core:PlantMachinery2022-04-012023-03-3106806698core:MotorVehicles2022-04-012023-03-3106806698core:BearerBiologicalAssetClass12022-04-012023-03-31068066982021-04-012022-03-3106806698core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-03-3106806698core:LandBuildingscore:OwnedOrFreeholdAssets2022-03-3106806698core:PlantMachinery2022-03-3106806698core:MotorVehicles2022-03-31068066982022-03-3106806698core:BearerBiologicalAssetClass12022-03-3106806698core:BearerBiologicalAssetClass12023-03-3106806698core:BearerBiologicalAssetClass12022-03-3106806698core:WithinOneYear2023-03-3106806698core:WithinOneYear2022-03-3106806698bus:PrivateLimitedCompanyLtd2022-04-012023-03-3106806698bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3106806698bus:FRS1022022-04-012023-03-3106806698bus:AuditExemptWithAccountantsReport2022-04-012023-03-3106806698bus:Director42022-04-012023-03-3106806698bus:CompanySecretary12022-04-012023-03-3106806698bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP